We are live on ! Find out more
BG

Bellevue Group Portfolio holdings

AUM $4.2B
1-Year Est. Return 54.85%
This Fund
S&P 500
This Quarter Est. Return
-10.66%
1 Year Est. Return
+54.85%
3 Year Est. Return
+140.3%
5 Year Est. Return
+171.01%
10 Year Est. Return
+915.55%
AUM
$551M
AUM Growth
–
Cap. Flow
+$550M
Cap. Flow %
99.74%
Top 10 Hldgs %
31.05%
Holding
130
New
130
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$21.7M
2
GILD icon
Gilead Sciences
GILD
+$21M
3
MDT icon
Medtronic
MDT
+$20.8M
4
BIIB icon
Biogen
BIIB
+$20.2M
5
AMGN icon
Amgen
AMGN
+$15.3M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 93%
2 Financials 1.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GERN icon
126
Geron
GERN
$911M
$131K 0.02%
+45,000
New +$135K
TTPH
127
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$102K 0.02%
+1,100
New +$110K
EIGR
128
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$56K 0.01%
+111
New +$55.3K
AST
129
DELISTED
Asterias Biotherapeutics Inc. Series A
AST
$9K ﹤0.01%
+1,875
New +$7.26K
BTX.WS
130
DELISTED
BioTime Inc Warrants (Expiring October 1, 2018)
BTX.WS
$1K ﹤0.01%
+2,294
New +$1.55K
2 3 4 5
6

Similar funds

WSFS
Wilmington Savings Fund Society Wilmington, Delaware $4.2B AUM 18.37% 1-Year Est. Return
AC
AlphaCore Capital La Jolla, California $4.22B AUM 21.28% 1-Year Est. Return
HIP
HUB Investment Partners Austin, Texas $4.18B AUM 24.76% 1-Year Est. Return
DT
DV Trading Chicago, Illinois $4.22B AUM
ATPW
Ashton Thomas Private Wealth Scottsdale, Arizona $4.23B AUM 20.9% 1-Year Est. Return
BT
Banque Transatlantique Paris, France $4.17B AUM 28.5% 1-Year Est. Return
NCM
Nearwater Capital Markets Dublin 4, Dublin, Ireland $4.24B AUM 66.03% 1-Year Est. Return
MSU
Mizuho Securities USA New York $4.24B AUM 23.1% 1-Year Est. Return

Bellevue Group's Q1 2016 Portfolio in Review

Q1 2016 is the first quarter with a 13F filing on record for Bellevue Group, which disclosed 130 positions worth $551M. Its ten largest holdings account for 31% of the portfolio.

Its largest position is Celgene Corp: 210,550 shares worth $21.1M.

By sector, the portfolio is most concentrated in Healthcare at 93% of assets, followed by Financials.

  • Bellevue Group's largest Q1 2016 buy was Celgene Corp: 210,550 shares worth $21.1M.
  • Bellevue Group's ten largest holdings make up 31% of its $551M portfolio in Q1 2016.
  • Bellevue Group disclosed 130 positions in Q1 2016, its first 13F filing on record.

Based on Bellevue Group's 13F filing for Q1 2016, filed 16 May 2016.